Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination
暂无分享,去创建一个
Tsonwin Hai | D. Boyd | D. Lu | Chunhong Yan
[1] D. Green,et al. Transcription, apoptosis and p53: catch-22. , 2005, Trends in genetics : TIG.
[2] Marc Prentki,et al. Role for Activating Transcription Factor 3 in Stress-Induced β-Cell Apoptosis , 2004, Molecular and Cellular Biology.
[3] S. Grossman,et al. Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.
[4] Muyang Li,et al. Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2 , 2003, Science.
[5] U. Moll,et al. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down‐regulation of the p53 response after multiple types of DNA damage , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] W. Gu,et al. Direct Interactions between HIF-1α and Mdm2 Modulate p53 Function* , 2003, The Journal of Biological Chemistry.
[7] J. Massagué,et al. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. , 2003, Molecular cell.
[8] K. Roemer,et al. Inhibition of p53 protects liver tissue against endotoxin‐induced apoptotic and necrotic cell death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] M. Terris,et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. , 2003, The American journal of pathology.
[10] Patrick J. Paddison,et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo , 2003, Nature Genetics.
[11] José A Fernández,et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective , 2003, Nature Medicine.
[12] M. Oren,et al. The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.
[13] D. Boyd,et al. Repression of 92-kDa Type IV Collagenase Expression by MTA1 Is Mediated through Direct Interactions with the Promoter via a Mechanism, Which Is Both Dependent on and Independent of Histone Deacetylation* , 2003, The Journal of Biological Chemistry.
[14] S. Murray,et al. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response , 2002, Nature.
[15] S. Volinia,et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults , 2002, Nature.
[16] K. Vousden. Activation of the p53 tumor suppressor protein. , 2002, Biochimica et biophysica acta.
[17] D. Woods,et al. C-Terminal Ubiquitination of p53 Contributes to Nuclear Export , 2001, Molecular and Cellular Biology.
[18] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] Z. Ronai,et al. The Mdm-2 Amino Terminus Is Required for Mdm2 Binding and SUMO-1 Conjugation by the E2 SUMO-1 Conjugating Enzyme Ubc9* , 2001, The Journal of Biological Chemistry.
[20] A. Ciechanover,et al. c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination , 2001, Molecular and Cellular Biology.
[21] Tsonwin Hai,et al. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. , 2001, Gene.
[22] M. Murphy,et al. The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated Degradation , 2001, Molecular and Cellular Biology.
[23] J. Manfredi,et al. Stabilization and Activation of p53 by the Coactivator Protein TAFII31* , 2001, The Journal of Biological Chemistry.
[24] Ettore Appella,et al. p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2 , 2001, The EMBO journal.
[25] J. Roth,et al. Multiple Lysine Mutations in the C-Terminal Domain of p53 Interfere with MDM2-Dependent Protein Degradation and Ubiquitination , 2000, Molecular and Cellular Biology.
[26] R. Hay,et al. Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation , 2000, Molecular and Cellular Biology.
[27] C. Maki,et al. The MDM2 RING-finger domain is required to promote p53 nuclear export , 2000, Nature Cell Biology.
[28] M. Nagata,et al. Apoptosis and p53 protein expression increase in the process of burn wound healing in guinea‐pig skin , 1999, The British journal of dermatology.
[29] G. Wahl,et al. A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.
[30] R. Honda,et al. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 , 1999, The EMBO journal.
[31] L. Neckers,et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1α , 1998, Nature.
[32] M. Kirschner,et al. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. , 1998, Genes & development.
[33] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[34] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[35] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[36] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[37] C. Wolfgang,et al. Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10 , 1996, Molecular and cellular biology.
[38] Guillermina Lozano,et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.
[39] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[40] A. Levine,et al. Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression , 1995, Molecular and cellular biology.
[41] D. Housman,et al. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] R Taub,et al. Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration , 1992, Molecular and cellular biology.
[43] Mark D. Johnson,et al. p53-Dependent Cell Death Signaling in Neurons , 2004, Neurochemical Research.
[44] A. Multani,et al. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice , 2004, Nature Genetics.
[45] Tsonwin Hai,et al. ATF3 and stress responses. , 1999, Gene expression.